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Hyperglycemia and glycemic variability increase 
mortality and poor outcomes in adult and neonatal 
intensive care units (ICU, NICU). Safe, effective tight 
glycemic control has proven difficult due to significant 
insulin resistance and its dynamic change over time in 
these patients.
Successful glycemic control protocol design must 
account for glycemic variability. Model-fitted insulin 
sensitivity can provide a measure of the dynamic effects
of insulin in the context of a real-time, clinically viable
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MODELS AND METHODS
A clinically validated insulin-glucose model is used to identify hourly insulin sensitivity (SI ) from 
retrospective clinical data for ICU and NICU cohorts. The ICU cohorts contained 393 patients 
with 44,386 hours of data from patients on the SPRINT insulin/nutrition modulation protocol. 
The NICU cohort comprised 25 episodes of 
insulin infusions from 21 patients with 3,567 
hours of data.
Insulin sensitivity for both groups of data was 
fitted using integral-based fitting methods on 
models adapted to each patient group.
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RESULTS & OUTCOMES
The median insulin sensitivity for neonates was 0.68x10-3  L/(mU.min), 
compared to 0.24x10-3  L/(mU.min) for adults, and the 5%-95% data interval 
was [0.17 – 1.70]x10-3  L/(mU.min) for neonates and [0.06 – 0.79]x10-3  
L/(mU.min) for adults respectively. In healthy Type II diabetes, median 
insulin sensitivity is 1-2x10-3  L/(mU.min) for comparison.
Figure 1: Empirical probability distribution function of model-fitted insulin sensitivity in adult critical care (light 
grey) and neonatal (dark grey) cohorts. The shaded area of each plot is equal to 1.0. The 5%-95% range of 
insulin sensitivity for adult and neonatal cohorts are shown by the dashed and dash-dot lines respectively.
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Figure 3: Per-patient empirical distribution of insulin sensitivity for the neonatal cohort. Each line represents a 
fitted insulin sensitivity profile for each of the 25 retrospective data sets. The overlaid dashed line shows the 
median and the shaded region represents the 5%-95% range of per-patient insulin sensitivity. 
The range and variation of model-fitted insulin sensitivity has been studied in 
adult critical care populations. However, this research is the first time this 
form of modeling and analysis has been applied to a neonatal cohort. 
Higher median insulin sensitivity in neonates may be due to higher glucose 
turnover and higher metabolic clearance of insulin resulting in lower plasma 
insulin concentrations. 
The distribution of insulin sensitivity variation between adults and neonates, 
shown in Figure 2, is significantly different for intervals of 1-3 hours (p < 0.05, 
Mann-Whitney test). Additionally, the median values of ΔSI are not significantly 
different to zero over any time interval for either cohort.
Thus, noting the wider insulin sensitivity spread in Figure 1, NICU patients 
exhibit less inter-patient variation and higher inter-patient variation 
compared to adults. However, as seen in Figure 2, adult patients exhibit 
very high intra-patient variability.
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Figure 2: Temporal variation in insulin sensitivity for adult and neonatal cohorts. The left panel shows distribution of change in 
insulin sensitivity, and the right panel shows cumulative density functions for insulin sensitivity change for 1-4 hour intervals.
Finally, Figure 3 shows that each NICU patient has a 
uniquely identified insulin sensitivity profile, further 
highlighting the importance of accurate identification for 
tight control. 
Overall, typical fixed insulin dosing protocols (e.g. 
sliding scales) will often fail to consistently provide 
effective glycemic control in both cohorts due to the 
significant intra- and inter- patient variability in 
insulin sensitivity observed in these cohorts.
Typical T2DM
control setting. This data can be used to identify 
patterns and/or trends within patient groups and 
between patient groups, guiding the adaptation of 
therapies from the controlled adult intensive care 
environment to other critical care settings, less acute 
wards, and ambulatory cases.
Insulin sensitivity (SI ) and its hour-to-hour (ΔSI ) change 
are analyzed to define the inter- and intra- patient 
variability for both adult critical care and neonatal 
cohorts.
INTRODUCTION
